TY  - JOUR
T1  - DRug-eluting stents should not be used in st-elevated myocardial infarction with cardiogenic shock
AU  - Champion S, Gaüzère B, Lefor Y
Y1  - 2012/11/12
N1  - 10.1001/archinternmed.2012.4418
JO  - Archives of Internal Medicine
SP  - 1613
EP  - 1614
VL  - 172
IS  - 20
N2  - 
We would like to share our experience in our intensive care unit in which 249 patients presenting with a cardiogenic shock were retrospectively reviewed during 2 years. Of the 249 patients, 51 underwent a coronary stenting: 30 (59%) ended up with at least 1 DES and 21 (41%) with only a BMS. The choice of the device was made by the coronarographist, according to the French guidelines.2 Despite an aggressive support (78% had a counterpulsation, 43% an hemodialysis, and 10% an assist device), the mortality remained high, even with a trend in higher mortality in the DES group (53% vs 47%; P = .16). Even used on a liberal basis in patients with similar risk markers (ie, age, left ventricular ejection fraction, Simplified Acute Physiology Score [SAPSII] score3), the DES did not reduce that tremendous mortality rate. Major hemorrhages were diagnosed in 59% of the patient with a median of 3 packed red blood cells transfused. Antiplatelet therapy had to be stopped for a few days in nearly half of patients.

SN  - 0003-9926
M3  - doi: 10.1001/archinternmed.2012.4418
UR  - http://dx.doi.org/10.1001/archinternmed.2012.4418
ER  -